GlassScriptPhysician profile
Nancy M Chung
NPI 1124240080
$14,026.64
in general payments reported to CMS, 2019-2025
44 companies · $3,027 in 2025
The $3,027 reported for 2025 was more than what 84% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,751 · 2020: $1,732 · 2021: $1,130 · 2022: $1,629 · 2023: $1,985 · 2024: $2,771 · 2025: $3,027.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,570 · Education: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,569.73 |
| Education | $214.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,863.86 | 2019-2025 | Rinvoq |
| Genzyme Corporation | $1,133.63 | 2021-2025 | |
| Pfizer INC. | $1,131.99 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $1,092.17 | 2019-2025 | Winlevi, Absorica Ld, Blu-U |
| Arcutis Biotherapeutics, INC. | $936.86 | 2023-2025 | Zoryve |
| Incyte Corporation | $870.22 | 2021-2025 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $843.76 | 2019-2025 | Dupixent, Libtayo |
| Encore Dermatology INC. | $782.57 | 2019-2020 | |
| Galderma Laboratories, L.P. | $667.34 | 2019-2025 | Nemluvio, Aklief, Epsolay |
| Lilly USA, LLC | $481.34 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Amgen INC. | $460.21 | 2021-2025 | Otezla, Otezla |
| Novartis Pharmaceuticals Corporation | $398.43 | 2019-2025 | |
| Misonix INC | $349.01 | 2019-2021 | |
| Janssen Biotech, INC. | $248.71 | 2022-2025 | Tremfya, Simponi, Simponi Aria |
| Dermavant Sciences, INC. | $244.41 | 2023-2024 | Vtama |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $244.19 | 2019-2024 | |
| Journey Medical Corporation | $243.00 | 2019-2025 | |
| Almirall LLC | $240.58 | 2022-2025 | Seysara, Klisyri |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $226.94 | 2020-2025 | Cabtreo, Siliq, Jublia |
| Leo Pharma INC. | $215.05 | 2019-2025 | Adbry, Anzupgo |
| E.R. Squibb & Sons, L.L.C. | $173.99 | 2022-2024 | Sotyktu |
| Boehringer Ingelheim Pharmaceuticals, INC. | $163.97 | 2024 | Spevigo |
| Vyne Pharmaceuticals INC. | $150.08 | 2020-2021 | |
| Organon LLC | $134.56 | 2025 | Vtama |
| Strata Skin Sciences, INC. | $91.86 | 2022-2025 | Xtrac |
| Epi Health, LLC | $74.59 | 2019 | |
| Sunovion Pharmaceuticals INC. | $63.71 | 2020 | |
| Medimetriks Pharmaceuticals, INC. | $59.24 | 2020-2025 | Neo-Synalar, Clindacin Etz |
| Ucb, INC. | $48.74 | 2019-2021 | |
| Merz North America, INC. | $46.38 | 2019-2023 | Xeomin |
| Allergan, INC. | $43.32 | 2020 | |
| Nabriva Therapeutics, Plc | $34.41 | 2021-2022 | |
| Erbe USA INC | $33.66 | 2021 | |
| Aclaris Therapeutics, INC. | $30.64 | 2019 | |
| Cipher Pharmaceuticals US LLC | $29.17 | 2025 | Natroba, Spinosad |
| Tactile Systems Technology INC | $28.01 | 2020 | |
| Dermira, INC. | $25.99 | 2019-2021 | |
| Dusa Pharmaceuticals, INC. | $24.98 | 2019 | |
| Biofrontera INC. | $18.27 | 2025 | Ameluz |
| Smith+Nephew, INC. | $16.79 | 2025 | Collagenase Santyl |
| Verrica Pharmaceuticals INC. | $16.02 | 2025 | Ycanth |
| Boston Scientific Corporation | $15.21 | 2024 | Varithena Administration Pack |
| Sanofi-Aventis U.S. LLC | $14.50 | 2021 | |
| Botanix Sb INC | $14.28 | 2025 | Sofdra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Chung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.